Corbus Pharmaceuticals (NASDAQ:CRBP) announced its Q4 earnings on Monday, March 9, 2026 at 07:30 AM.
Here’s a breakdown of the earnings report.
Earnings
Corbus Pharmaceuticals beat estimated earnings by 24.7%, reporting an EPS of $-1.25 versus an estimate of $-1.66.
Revenue was down $0 from the same period last year.
Overview of Past Earnings
The company missed …